EARNEST Partners’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $41.5M | Sell |
|
|||||
2025
Q1 | $54.4M | Sell |
|
|||||
2024
Q4 | $63.8M | Sell |
|
|||||
2024
Q3 | $69.6M | Buy |
|
|||||
2024
Q2 | $66.7M | Buy |
|
|||||
2024
Q1 | $52.8M | Sell |
|
|||||
2023
Q4 | $65.8M | Sell |
|
|||||
2023
Q3 | $90.8M | Sell |
|
|||||
2023
Q2 | $89.2M | Buy |
|
|||||
2023
Q1 | $78.6M | Sell |
|
|||||
2022
Q4 | $72.4M | Buy |
|
|||||
2022
Q3 | $44.7M | Buy |
|
|||||
2022
Q2 | $65.4M | Sell |
|
|||||
2022
Q1 | $108M | Sell |
|
|||||
2021
Q4 | $76.6M | Sell |
|
|||||
2021
Q3 | $99.7M | Sell |
|
|||||
2021
Q2 | $150M | Sell |
|
|||||
2021
Q1 | $123M | Buy |
|
|||||
2020
Q4 | $113M | Buy |
|
|||||
2020
Q3 | $63.8M | Buy |
|
|||||
2020
Q2 | $74.8M | Buy |
|
|||||
2020
Q1 | $30.6M | Buy |
|
|||||
2019
Q4 | $111M | Buy |
|
|||||
2019
Q3 | $134M | Buy |
|
|||||
2019
Q2 | $121M | Buy |
|
|||||
2019
Q1 | $133M | Buy |
|
|||||
2018
Q4 | $114M | Sell |
|
|||||
2018
Q3 | $224M | Sell |
|
|||||
2018
Q2 | $246M | Buy |
|
|||||
2018
Q1 | $211M | Sell |
|
|||||
2017
Q4 | $214M | Buy |
|
|||||
2017
Q3 | $193M | Buy |
|
|||||
2017
Q2 | $186M | Sell |
|
|||||
2017
Q1 | $213M | Sell |
|
|||||
2016
Q4 | $224M | Sell |
|
|||||
2016
Q3 | $218M | Sell |
|
|||||
2016
Q2 | $251M | Sell |
|
|||||
2016
Q1 | $266M | Sell |
|
|||||
2015
Q4 | $271M | Sell |
|
|||||
2015
Q3 | $257M | Sell |
|
|||||
2015
Q2 | $295M | Buy |
|
|||||
2015
Q1 | $265M | Sell |
|
|||||
2014
Q4 | $322M | Buy |
|
|||||
2014
Q3 | $387M | Sell |
|
|||||
2014
Q2 | $456M | Sell |
|
|||||
2014
Q1 | $550M | Sell |
|
|||||
2013
Q4 | $546M | Buy |
|